Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Neuroimage. Clinical
|
March 31, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and <sup>18</sup>F-FDG-PET imaging
Julie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, et al.
Journal of Neurotrauma
|
July 24, 2018
Neuroimaging of Subacute Brain Inflammation and Microstructural Changes Predicts Long-Term Functional Outcome after Experimental Traumatic Brain Injury
Stephan Missault, Cynthia Anckaerts, Ines Blockx, et al.
Plos One
|
March 4, 2014
Absence of cardiovascular manifestations in a haploinsufficient Tgfbr1 mouse model
Marjolijn Renard, Bram Trachet, Christophe Casteleyn, et al.
Brain, Behavior, and Immunity
|
December 4, 2018
State-associated changes in longitudinal [<sup>18</sup>F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?
Livia De Picker, Julie Ottoy, Jeroen Verhaeghe, et al.
Nature Genetics
|
August 16, 2011
A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
Mourad Matmati, Peggy Jacques, Jonathan Maelfait, et al.
Journal of Alzheimer'S Disease : JAD
|
September 5, 2017
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
Ellis Niemantsverdriet, Julie Ottoy, Charisse Somers, et al.
Neurobiology of Disease
|
April 9, 2025
Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
Deanna M Marchionini, Stef De Lombaerde, Joëlle van Rijswijk, et al.
Science Translational Medicine
|
February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
Daniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Journal of Medicinal Chemistry
|
December 22, 2022
Design and Evaluation of [<sup>18</sup>F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates
Longbin Liu, Peter D Johnson, Michael E Prime, et al.
Journal of Medicinal Chemistry
|
September 26, 2025
Correction to "Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates"
Longbin Liu, Peter D Johnson, Matthew R Mills, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Neuroimage. Clinical
|
March 31, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and <sup>18</sup>F-FDG-PET imaging
Julie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, et al.
Journal of Neurotrauma
|
July 24, 2018
Neuroimaging of Subacute Brain Inflammation and Microstructural Changes Predicts Long-Term Functional Outcome after Experimental Traumatic Brain Injury
Stephan Missault, Cynthia Anckaerts, Ines Blockx, et al.
Plos One
|
March 4, 2014
Absence of cardiovascular manifestations in a haploinsufficient Tgfbr1 mouse model
Marjolijn Renard, Bram Trachet, Christophe Casteleyn, et al.
Brain, Behavior, and Immunity
|
December 4, 2018
State-associated changes in longitudinal [<sup>18</sup>F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?
Livia De Picker, Julie Ottoy, Jeroen Verhaeghe, et al.
Nature Genetics
|
August 16, 2011
A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
Mourad Matmati, Peggy Jacques, Jonathan Maelfait, et al.
Journal of Alzheimer'S Disease : JAD
|
September 5, 2017
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
Ellis Niemantsverdriet, Julie Ottoy, Charisse Somers, et al.
Neurobiology of Disease
|
April 9, 2025
Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
Deanna M Marchionini, Stef De Lombaerde, Joëlle van Rijswijk, et al.
Science Translational Medicine
|
February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
Daniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Journal of Medicinal Chemistry
|
December 22, 2022
Design and Evaluation of [<sup>18</sup>F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates
Longbin Liu, Peter D Johnson, Michael E Prime, et al.
Journal of Medicinal Chemistry
|
September 26, 2025
Correction to "Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates"
Longbin Liu, Peter D Johnson, Matthew R Mills, et al.
Page
of 17